Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology

Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology

Masitinib is a protein kinase inhibitor that sensitises refractory pancreatic adenocarcinoma cells to treatment with the nucleoside analog gemcitabine. Here the authors show that Masitinib activates deoxycytidine kinase to enhance phosphorylation of nucleoside analogue pro-drugs, increasing their po...

Full description

Saved in:
Bibliographic Details
Main Authors: Kahina Hammam, Magali Saez-Ayala, Etienne Rebuffet, Laurent Gros, Sophie Lopez, Berengere Hajem, Martine Humbert, Emilie Baudelet, Stephane Audebert, Stephane Betzi, Adrien Lugari, Sebastien Combes, Sebastien Letard, Nathalie Casteran, Colin Mansfield, Alain Moussy, Paulo De Sepulveda, Xavier Morelli, Patrice Dubreuil
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Science
Q
Online Access:https://doaj.org/article/17f65d9ef23b487fb909bb37564ae125
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/17f65d9ef23b487fb909bb37564ae125

Similar Items